Cigna has announced that it will begin covering Cleerly LABS Advanced Plaque Analysis, effective October 1, 2025. This decision positions Cigna as the latest major insurer to recognize the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) technology for cardiovascular care.
This landmark decision expands access to AI-guided quantitative coronary CT angiography for millions of Americans. With Cigna covering more than 16 million lives, this new policy will significantly broaden the availability of advanced plaque analysis, which is crucial for early detection and management of cardiovascular disease.
The adoption of Cleerly's AI-based technology underscores Cigna's commitment to integrating innovative solutions that improve health outcomes and enhance patient care. This operational milestone strengthens Cigna's position in offering cutting-edge diagnostic services to its members.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.